NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 18.12% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 14.73% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 7.32% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 5.28% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.65% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 4.37% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.14% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 3.30% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.06% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.71% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.63% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.45% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.41% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| LNTH | Lantheus Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.30% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
| MLTX_old | Multex Com Inc | Other | Other | 1.92% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.92% |